Non–Vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation and Associated Intracranial Hemorrhage: A Focused Review

Publisher： John Wiley & Sons Inc

E-ISSN： 1932-8737|38|11|684-691

ISSN： 0160-9289

Source： Clinical Cardiology, Vol.38, Iss.11, 2015-11, pp. : 684-691

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intracranial Hemorrhage and Oral Anticoagulant Treatment

By  

Cerebrovascular Diseases, Vol. 11, Iss. 3, 2001-04 ,pp. : 195-200

Karger

Access to resources Recommend Favorite

Epidemiology of Intracranial Haemorrhages Associated with Vitamin K Antagonist Oral Anticoagulants in Spain: TAC Registry

By  

Interventional Neurology, Vol. 4, Iss. 1-2, 2015-0 ,pp. : 52-58

Karger

Access to resources Recommend Favorite

Non-Vitamin K Oral Anticoagulants (NOACs) A Review of Clinical Management and Laboratory Issues

By  

Current Vascular Pharmacology, Vol. 14, Iss. 3, 2016-05 ,pp. : 220-236

Bentham Science Publishers

Access to resources Recommend Favorite

Vitamin K for the Treatment of Asymptomatic Coagulopathy Associated with Oral Anticoagulant Therapy

By Crowther Mark A.   Wilson Sarah  

Journal of Thrombosis and Thrombolysis, Vol. 16, Iss. 1-2, 2003-08 ,pp. : 69-72

Springer Publishing Company

Access to resources Recommend Favorite

Prescription of vitamin K inhibitors in low-risk patients with atrial fibrillation

By Granziera S.  

Journal of Thrombosis and Thrombolysis, Vol. 31, Iss. 4, 2011-05 ,pp. : 501-502

Springer Publishing Company

Access to resources Recommend Favorite